Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1–11.

Article  CAS  PubMed  Google Scholar 

Corral-Gudino L, Borao-Cengotita-Bengoa M, Del Pino-Montes J, Lerma-Márquez JL. Overall survival, renal survival and relapse in patients with microscopic polyangiitis: a systematic review of current evidence. Rheumatology (Oxford). 2011;50(8):1414–23.

Article  PubMed  Google Scholar 

Borao-Cengotita-Bengoa M, Corral-Gudino L, Del Pino-Montes J, Lerma-Márquez JL. Long-term follow-up of microscopic polyangiitis, 17-year experience at a single center. Eur J Intern Med. 2010;21(6):542–7.

Article  PubMed  Google Scholar 

Phillip R, Luqmani R. Mortality in systemic vasculitis: a systematic review. Clin Exp Rheumatol. 2008;26(5 Suppl 51):S94-104.

CAS  PubMed  Google Scholar 

Mun CH, Yoo J, Jung SM, Song JJ, Park YB, Lee SW. The initial predictors of death in 153 patients with ANCA-associated vasculitis in a single Korean centre. Clin Exp Rheumatol. 2018;36:65–72.

PubMed  Google Scholar 

Bourgarit A, Toumelin PL, Pagnoux C, Cohen P, Mahr A, Guern VL, Mouthon L, French Vasculitis Study Group, et al. Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: a retrospective analysis of causes and factors predictive of mortality based on 595 patients. Medicine (Baltimore). 2005;84(5):323–30.

Article  PubMed  Google Scholar 

Takakuwa Y, Yamasaki Y, Matsushita H, Kiyokawa T, Mizushima M, Tonooka K, et al. Long-term survival, causes of death, and prognostic factors for mortality in patients with microscopic polyangiitis and those with anti-neutrophil cytoplasmic antibody-positive interstitial lung disease: a single-center retrospective study. Int J Rheum Dis. 2023;26(3):446–53.

Article  CAS  PubMed  Google Scholar 

Gu Y, Zhang T, Peng M, Shi JH. Characteristics and prognosis of microscopic polyangiitis patients with diffuse alveolar hemorrhage and interstitial lung disease. Chin Med Sci J. 2022;37(4):293–302.

PubMed  Google Scholar 

Nguyen Y, Pagnoux C, Karras A, Quéméneur T, Maurier F, Hamidou M, French Vasculitis Study Group, et al. Microscopic polyangiitis: clinical characteristics and long-term outcomes of 378 patients from the French Vasculitis Study Group Registry. J Autoimmun. 2020;112:102467.

Article  CAS  PubMed  Google Scholar 

Wang Q, Mou S, Xu W, Qi C, Ni Z. Predicting mortality in microscopic polyangiitis with renal involvement: a survival analysis based on 64 patients. Ren Fail. 2013;35(1):82–7.

Article  PubMed  Google Scholar 

Matsuda S, Kotani T, Suzuka T, Kiboshi T, Fukui K, Wakama M, et al. Evaluation of poor prognostic factors of respiratory related death in microscopic polyangiitis complicated by interstitial lung disease. Sci Rep. 2021;11(1):1490.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B, Dubey S, Flossmann O, Hall C, Hollywood J, Jayne D, Jones R, Lanyon P, Muir A, Scott D, Young L, Luqmani RA. Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis. 2009;68(12):1827–32.

Article  CAS  PubMed  Google Scholar 

Hellmich B, Flossmann O, Gross WL, Bacon P, Cohen-Tervaert JW, Guillevin L, et al. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis. 2007;66(5):605–17.

Article  CAS  PubMed  Google Scholar 

Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Toumelin PL, French Vasculitis Study Group (FVSG). The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore). 2011;90(1):19–27.

Article  PubMed  Google Scholar 

Sugiyama Y, Yoshimi R, Tamura M, Takeno M, Kunishita Y, Kishimoto D, et al. The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease. Arthritis Res Ther. 2018;20(1):7.

Article  PubMed  PubMed Central  Google Scholar 

Gono T, Masui K, Nishina N, Kawaguchi Y, Kawakami A, Ikeda K, the Multicenter Retrospective Cohort of Japanese Patients with Myositis-Associated ILD (JAMI) Investigators, et al. Risk prediction modeling based on a combination of initial serum biomarker levels in polymyositis/dermatomyositis-associated interstitial lung disease. Arthritis Rheumatol. 2021;73(4):677–86.

Article  CAS  PubMed  Google Scholar 

Suppiah R, Mukhtyar C, Flossmann O, Alberici F, Baslund B, Batra R, et al. A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis. Rheumatology (Oxford). 2011;50(5):899–905.

Article  PubMed  Google Scholar 

Solans-Laqué R, Rodriguez-Carballeira M, Rios-Blanco JJ, Fraile G, Sáez-Comet L, Martinez-Zapico A, Spanish Registry of Systemic Vasculitis, the Autoimmune Systemic Diseases Study Group, and the Spanish Society of Internal Medicine, et al. Comparison of the Birmingham Vasculitis Activity Score and the Five-Factor Score to assess survival in antineutrophil cytoplasmic antibody-associated vasculitis: a study of 550 patients from Spain (REVAS Registry). Arthritis Care Res (Hoboken). 2020;72(7):1001–10.

Article  PubMed  Google Scholar 

Ahn JK, Hwang JW, Lee J, Jeon CH, Cha HS, Koh EM. Clinical features and outcome of microscopic polyangiitis under a new consensus algorithm of ANCA-associated vasculitides in Korea. Rheumatol Int. 2012;32(10):2979–86.

Article  PubMed  Google Scholar 

Itabashi M, Takei T, Morito T, Yabuki Y, Suzuki H, Ando M, et al. Estimation of BVAS in patients with microscopic polyangiitis in Japan. Clin Rheumatol. 2011;30(11):1499–505.

Article  PubMed  Google Scholar 

Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, European Vasculitis Study Group, et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis. 2009;68(3):310–7.

Article  CAS  PubMed  Google Scholar 

Sada KE, Yamamura M, Harigai M, Fujii T, Takasaki Y, Amano K, Research Committee on Intractable Vasculitides, the Ministry of Health, Labour and Welfare of Japan, et al. Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study. Arthritis Res Ther. 2015;17:305.

Article  PubMed  PubMed Central  Google Scholar 

Samson M, Devilliers H, Thietart S, Charles P, Pagnoux C, Cohen P, et al. Score to assess the probability of relapse in granulomatosis with polyangiitis and microscopic polyangiitis. RMD Open. 2023;9(1):e002953.

Article  PubMed  PubMed Central  Google Scholar 

Suppiah R, Judge A, Batra R, Flossmann O, Harper L, Höglund P, et al. A model to predict cardiovascular events in patients with newly diagnosed Wegener’s granulomatosis and microscopic polyangiitis. Arthritis Care Res (Hoboken). 2011;63(4):588–96.

Article  PubMed  Google Scholar 

Chen Z, Tian X, Qu J, Chen J, Yang Y, Li J. Development and internal validation of a model to predict long-term survival of ANCA associated vasculitis. Rheumatol Immunol Res. 2023;4(1):30–9.

Article  PubMed  PubMed Central  Google Scholar